SynthesisThe clinical respiratory journal2024

The impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non-small cell lung cancer: A meta-analysis.

Liuxian Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.